Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Heublein

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Mayo Clinic Proceedings|March 9, 1999
Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failureJ A Schirger, D M Heublein, H H Chen, et al.
Kidney International|August 5, 1999
Renal actions of synthetic dendroaspis natriuretic peptideO Lisy, M Jougasaki, D M Heublein, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1994
Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitorT L Stevens, C M Wei, L L Aahrus, et al.
The American Journal of Physiology|December 11, 1994
CNP is present in canine renal tubular cells and secreted by cultured opossum kidney cellsA Nir, K W Beers, A L Clavell, et al.
Lancet (London, England)|May 1, 1993
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunctionA Lerman, R J Gibbons, R J Rodeheffer, et al.
Mayo Clinic Proceedings|July 1, 1986
The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failureB S Edwards, D M Ackermann, T R Schwab, et al.
The Journal of Clinical Investigation|March 1, 1996
Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constrictionA L Clavell, M T Mattingly, T L Stevens, et al.
Kidney International|November 1, 1996
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failureT Supaporn, S M Sandberg, D D Borgeson, et al.
Mayo Clinic Proceedings|November 1, 1990
Endothelin: a new cardiovascular regulatory peptideA Lerman, F L Hildebrand, K B Margulies, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1996
Angiotensin II in the evolution of experimental heart failureA Luchner, T L Stevens, D D Borgeson, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Mayo Clinic Proceedings|March 9, 1999
Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failureJ A Schirger, D M Heublein, H H Chen, et al.
Kidney International|August 5, 1999
Renal actions of synthetic dendroaspis natriuretic peptideO Lisy, M Jougasaki, D M Heublein, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1994
Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor inhibitorT L Stevens, C M Wei, L L Aahrus, et al.
The American Journal of Physiology|December 11, 1994
CNP is present in canine renal tubular cells and secreted by cultured opossum kidney cellsA Nir, K W Beers, A L Clavell, et al.
Lancet (London, England)|May 1, 1993
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunctionA Lerman, R J Gibbons, R J Rodeheffer, et al.
Mayo Clinic Proceedings|July 1, 1986
The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failureB S Edwards, D M Ackermann, T R Schwab, et al.
The Journal of Clinical Investigation|March 1, 1996
Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constrictionA L Clavell, M T Mattingly, T L Stevens, et al.
Kidney International|November 1, 1996
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failureT Supaporn, S M Sandberg, D D Borgeson, et al.
Mayo Clinic Proceedings|November 1, 1990
Endothelin: a new cardiovascular regulatory peptideA Lerman, F L Hildebrand, K B Margulies, et al.
Hypertension (Dallas, Tex. : 1979)|September 1, 1996
Angiotensin II in the evolution of experimental heart failureA Luchner, T L Stevens, D D Borgeson, et al.
Pageof 6